Mounjaro by Eli Lilly is a next-generation prescription medication designed to tackle two major health concerns: obesity and type 2 diabetes. Powered by the active ingredient tirzepatide, Mounjaro offers a unique dual-action approach by targeting both GLP-1 and GIP receptors—natural hormones that regulate appetite, insulin levels, and blood sugar control.
More about Mounjaro
This once-weekly, self-injectable treatment is clinically proven to deliver exceptional results. In trials, patients experienced up to 22.5% body weight reduction over 72 weeks, along with significantly improved blood sugar management. By reducing hunger, slowing stomach emptying, and enhancing insulin sensitivity, Mounjaro provides a comprehensive solution for long-term metabolic health.
Why Choose Mounjaro?
- Clinically proven weight loss in individuals with obesity or weight-related conditions
- Effective blood sugar control for type 2 diabetes
- Tailored dosing options from 2.5mg to 15mg to fit your needs
- Convenient pre-filled pen, easy to use at home once a week
Whether you're focused on managing type 2 diabetes, losing weight, or both, Mounjaro offers a powerful new way forward—backed by science and trusted by healthcare professionals worldwide.
New customers should start with Mounjaro step 1.
What to know more about weight loss with injectables? Read our extensive Mounjaro FAQ.
